Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial
Anna Caroli(Mario Negri Institute for Pharmacological Research), Norberto Perico(Istituti di Ricovero e Cura a Carattere Scientifico), Annalisa Perna(Mario Negri Institute for Pharmacological Research), Luca Antiga(Mario Negri Institute for Pharmacological Research), Paolo Brambilla(Ospedale Papa Giovanni XXIII), Antonio Pisani, Bianca Visciano, Massimo Imbriaco(University of Naples Federico II), Piergiorgio Messa(Ospedale Maggiore), Roberta Cerutti(Ospedale Maggiore), Mauro Dugo(Ca' Foncello Hospital), Luca Cancian(Ca' Foncello Hospital), Erasmo Buongiorno(Ospedale Vito Fazzi), Antonio De Pascalis(Ospedale Vito Fazzi), Flavio Gaspari(Mario Negri Institute for Pharmacological Research), Fabiola Carrara(Istituti di Ricovero e Cura a Carattere Scientifico), Nadia Rubis(Istituti di Ricovero e Cura a Carattere Scientifico), Silvia Prandini(Istituti di Ricovero e Cura a Carattere Scientifico), Andrea Remuzzi(University of Bergamo), Giuseppe Remuzzi(Mario Negri Institute for Pharmacological Research), Piero Ruggenenti(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 252
Abstract
Related Papers
No related papers found
Powered by citation graph analysis